Trial intelligence / Profile preview

MnSOD PL for Radiation-Induced Esophagitis in NSCLC

NCT00618917Phase 2Terminated

Start
Nov 2005
Primary completion
Feb 2010
Modality
Gene Editing, Prophylactic Vaccines, Gene Silencing
Countries
1
01

Overview

A Phase 2 trial of manganese superoxide dismutase plasmid liposome in radiation-induced esophagitis. Started Nov 2005; status: terminated.

02

Drugs

manganese superoxide dismutase plasmid liposome
03

Conditions

radiation-induced esophagitis

Beyond the preview

Go deeper on NCT00618917.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00618917.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call